Replies to post #428845 on Anavex Life Sciences Corp (AVXL)

[kund]

Like last Dec prediction, worldwide approval by mid 2023, here we are at 9month post CTAD and 12+ month post trial completion and still Misleading not able to get detail data from meager 500 patient trial, excellence will be another clown show once data comes out (big IF).